4 institutions hold shares in KemPharm Inc. (KMPH), with 322.73k shares held by insiders accounting for 7.12% while institutional investors hold 6.49% of the company’s shares. The shares outstanding are 4.43M, and float is at 3.95M with Short Float at 8.18%. Institutions hold 6.03% of the Float.
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free.
The top institutional shareholder in the company is Ifp Advisors, Inc with over 1250.0 shares valued at $14000.0. The investor’s holdings represent 0.03% of the KMPH Shares outstanding.
KemPharm Inc. (NASDAQ: KMPH) is -5.89% lower on its value in year-to-date trading and has touched a low of $1.94 and a high of $22.08 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The KMPH stock was last observed hovering at around $9.78 in the last trading session, with the day’s gains setting it 0.76% off its average median price target of $26.00 for the next 12 months. It is also 62.36% off the consensus price target high of $28.00 offered by 2 analysts, but current levels are 56.08% higher than the price target low of $24.00 for the same period.
Currently trading at $10.54, the stock is 34.09% and 4.61% above its SMA20 and SMA50 respectively. However, with a daily trading volume of 2.12 million and changing 7.77% at the moment leaves the stock 22.77% off its SMA200. KMPH registered 77.42% gain for a year compared to 6-month loss of -7.66%. The firm has a 50-day simple moving average (SMA 50) of $7.77 and a 200-day simple moving average (SMA200) of $10.71.
The stock witnessed a 73.36% gain in the last 1 month and extending the period to 3 months gives it a 2.93%, and is 10.71% up over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.71% over the week and 11.09% over the month.
KemPharm Inc. (KMPH) has around 22 employees, a market worth around $184.45M and $12.30M in sales. Fwd P/E is 3.50. Distance from 52-week low is 444.42% and -52.26% from its 52-week high. The company has generated returns on investments over the last 12 months (-634.80%).
KemPharm Inc. (KMPH) Analyst Forecasts
Analyst recommendations provided by FactSet shows that the consensus forecast for KemPharm Inc. (KMPH) is a “Buy”. 2 analysts offering their recommendations for the stock have an average rating of 2.00, where 0 rate it as a Hold and 0 think it is a “Overweight”. 2 of the analysts rate the stock as a “Buy”. 0 analysts have rated the stock as a Sell or Underperform.
KemPharm Inc. is expected to release its quarterly report on 05/13/2021 and quarterly earnings per share for the current quarter are estimated at -$0.56 with sales reaching $2.95M over the same period.The EPS is expected to grow by 73.70% this year, but quarterly earnings will post 8.00% year-over-year. Quarterly sales are estimated to grow 114.40% in year-over-year returns.
KemPharm Inc. (KMPH) Insider Activity
A total of 1 insider transactions have happened at KemPharm Inc. (KMPH) in the last six months, with sales accounting for 0 and purchases happening 1 times. The most recent transaction is an insider purchase by Clifton R. LaDuane, the company’s CFO, Secretary & Treasurer. SEC filings show that Clifton R. LaDuane bought 1,000 shares of the company’s common stock on Mar 25 at a price of $0.22 per share for a total of $218.0. Following the purchase, the insider now owns 34000.0 shares.
KemPharm Inc. disclosed in a document filed with the SEC on Mar 13 that Sangiovanni Timothy J. (VP, Corporate Controller) bought a total of 4,000 shares of the company’s common stock. The trade occurred on Mar 13 and was made at $0.20 per share for $800.0. Following the transaction, the insider now directly holds 18000.0 shares of the KMPH stock.
Still, SEC filings show that on Mar 11, Clifton R. LaDuane (CFO, Secretary & Treasurer) acquired 8,000 shares at an average price of $0.25 for $2010.0. The insider now directly holds 33,000 shares of KemPharm Inc. (KMPH).